Filing Details
- Accession Number:
- 0001209191-18-045747
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-07 17:55:27
- Reporting Period:
- 2018-08-06
- Accepted Time:
- 2018-08-07 17:55:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820081 | Cambrex Corp | CBM | Pharmaceutical Preparations (2834) | 222476135 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632229 | Samantha Hanley | One Meadowlands Plaza East Rutherford NJ 07073 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-06 | 2,500 | $16.91 | 2,500 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-06 | 2,500 | $17.81 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-06 | 3,750 | $22.50 | 8,750 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-06 | 12,500 | $41.36 | 21,250 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-06 | 6,250 | $40.65 | 27,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-06 | 19,900 | $62.36 | 7,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-06 | 7,600 | $63.38 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-08-06 | 2,500 | $0.00 | 2,500 | $16.91 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-08-06 | 2,500 | $0.00 | 2,500 | $17.81 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-08-06 | 3,750 | $0.00 | 3,750 | $22.50 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-08-06 | 12,500 | $0.00 | 12,500 | $41.36 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2018-08-06 | 6,250 | $0.00 | 6,250 | $40.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-10-28 | No | 4 | M | Direct | |
| 2,500 | 2021-10-22 | No | 4 | M | Direct | |
| 3,750 | 2022-01-28 | No | 4 | M | Direct | |
| 12,500 | 2022-10-21 | No | 4 | M | Direct | |
| 18,750 | 2023-10-26 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.95 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.05 to $63.68 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 2 to this Form 4.
- The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 28, 2014, which was the first anniversary of the date on which the option was granted
- The option representing a right to purchase 10,000 shares became exercisable in four equal installments beginning October 22, 2015, which was the first anniversary of the date on which the option was granted
- The option representing a right to purchase 15,000 shares became exercisable in four equal installments beginning January 28, 2016, which was the first anniversary of the date on which the option was granted
- The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 21, 2016, which was the first anniversary of the date on which the option was granted
- The option representing a right to purchase 25,000 shares became exercisable in four equal installments beginning October 26, 2017, which was the first anniversary of the date on which the option was granted
Billionaire Hedge Funds
